The 81st Annual Meeting of the Japanese Society of Hematology

Session information

Oral Session

Oral Session 2-10D ATL/HTLV-1: Molecular Mechanism/Therapeutic Target

Sat. Oct 12, 2019 4:00 PM - 5:00 PM No.10 (Tokyo International Forum, 4F G409)

Chair: Jun-ichirou Yasunaga (Laboratory of Virus Control, Institute for Frontier Life and Medical Sciences, Kyoto University)

Shugo Sakihama1, Kazuho Morichika2, Megumi Miyara3, Takashi Miyagi4, Masaki Hayashi5, Junnosuke Uchihara6, Takeaki Tomoyose7, Sawako Nakachi2, Satoko Morishima2, Kazuko Sakai8, Kazuto Nishio8, Hiroaki Masuzaki2, Takuya Fukushima9, Kennosuke Karube1 (1.Pathol. and Cell Biol., Ryukyu Univ., Okinawa, Japan, 2.Second Department of Internal Medicine, Ryukyu Univ., Okinawa, Japan, 3.Health and Nutrition, Okinawa Univ., Okinawa, Japan, 4.Hemato., Heartlife Hosp., Okinawa, Japan, 5.Hemato., Nakagami Hosp., Okinawa, Japan, 6.Hematol., Naha-City Hosp., Okinawa, Japan, 7.Hematol., Okinawa Prefectural Nanbu Medical Center, Okinawa, Japan, 8.Genome Biol., Kindai Univ., Osaka, Japan, 9.Hematoimmunol., Ryukyu Univ., Okinawa, Japan)

Tatsuro Watanabe1, Hiroshi Ureshino1, Kazuharu Kamachi1,2, Yuki Kurahashi1,3, Yuki Kurahashi1,3, Satoshi Yamashita4, Seiji Okada5, Toshikazu Ushijima4, Eisaburo Sueoka6, Shinya Kimura1,2 (1.Drug Discov. and Biomed. Sci., Saga Univ., Saga, Japan, 2.Dept. Hematology, Respiratory Medicine and Oncology, Saga Univ., Saga, Japan, 3.OHARA Pharmaceutical Co., Ltd., Shiga, Japan, 4.Div. Epigenomics, Natl. Cancer Ctr. Res. Inst., Tokyo, Japan, 5.Div. Hematopoiesis, Joint Res. Ctr. Human Retrovirus Infection, Kumamoto, Japan, 6.Dept. Clin. Lab. Med., Saga Univ., Saga, Japan)